Meta-Analysis: Convalescent Blood Products for Spanish Influenza Pneumonia: A Future H5N1 Treatment?, Annals of Internal Medicine, vol.145, issue.8, pp.599-609, 2006. ,
DOI : 10.7326/0003-4819-145-8-200610170-00139
Treatment with Convalescent Plasma for Influenza A (H5N1) Infection, New England Journal of Medicine, vol.357, issue.14, pp.1450-1451, 2007. ,
DOI : 10.1056/NEJMc070359
Prophylactic and Therapeutic Efficacy of Human Monoclonal Antibodies against H5N1 Influenza, PLoS Medicine, vol.8, issue.5, 2007. ,
DOI : 10.1371/journal.pmed.0040178.t002
Combinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategies, Proceedings of the National Academy of Sciences, vol.105, issue.16, pp.5986-5991, 2008. ,
DOI : 10.1073/pnas.0801367105
An Antibody That Prevents the Hemagglutinin Low pH Fusogenic Transition, Virology, vol.294, issue.1, pp.70-74, 2002. ,
DOI : 10.1006/viro.2001.1320
Spin-labeling of influenza virus hemagglutinin permits analysis of the conformational change at low pH and its inhibition by antibody, Virus Research, vol.4, issue.3, pp.251-261, 1986. ,
DOI : 10.1016/0168-1702(86)90004-3
The mechanism of neutralization of influenza virus infectivity by antibodies, Acta Crystallographica Section A Foundations of Crystallography, vol.58, issue.s1, pp.294-298, 2002. ,
DOI : 10.1107/S0108767302096204
Inhibition of virus-induced hemolysis with monoclonal antibodies to different antigenic areas on the hemagglutinin molecule of A/seal, H7N7) influenza virus, pp.91-99, 1983. ,
Association of Serum Anti-Neuraminidase Antibody with Resistance to Influenza in Man, New England Journal of Medicine, vol.286, issue.25, pp.1329-1332, 1972. ,
DOI : 10.1056/NEJM197206222862502
Induction of Partial Immunity to Influenza by a Neuraminidase-specific Vaccine, Journal of Infectious Diseases, vol.129, issue.4, pp.411-420, 1974. ,
DOI : 10.1093/infdis/129.4.411
Protective effects of specific immunity to viral neuraminidase on influenza virus infection of mice, J Virol, vol.2, pp.778-786, 1968. ,
Protection against lethal influenza with neuraminidase, Virology, vol.164, issue.1, pp.230-237, 1988. ,
DOI : 10.1016/0042-6822(88)90640-X
Heterosubtypic immunity to influenza A virus: where do we stand?, Microbes and Infection, vol.10, issue.9, pp.1024-1029, 2008. ,
DOI : 10.1016/j.micinf.2008.07.002
Ab and T cell epitopes of influenza A virus, knowledge and opportunities, Proceedings of the National Academy of Sciences, vol.104, issue.1, pp.246-251, 2007. ,
DOI : 10.1073/pnas.0609330104
A carbohydrate side chain on hemagglutinins of Hong Kong influenza viruses inhibits recognition by a monoclonal antibody., Proceedings of the National Academy of Sciences, vol.81, issue.6, pp.1779-1783, 1984. ,
DOI : 10.1073/pnas.81.6.1779
Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation, Nature, vol.49, issue.5796, pp.373-378, 1981. ,
DOI : 10.1038/289373a0
The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype), Cell, vol.31, issue.2, pp.417-427, 1982. ,
DOI : 10.1016/0092-8674(82)90135-0
Antigenic structure of the haemagglutinin of human influenza A/H2N2 virus, Journal of General Virology, vol.82, issue.10, pp.2475-2484, 2001. ,
DOI : 10.1099/0022-1317-82-10-2475
Structure of antigenic sites on the haemagglutinin molecule of H5 avian influenza virus and phenotypic variation of escape mutants, Journal of General Virology, vol.83, issue.10, pp.2497-2505, 2002. ,
DOI : 10.1099/0022-1317-83-10-2497
Epitope Mapping of the Hemagglutinin Molecule of a Highly Pathogenic H5N1 Influenza Virus by Using Monoclonal Antibodies, Journal of Virology, vol.81, issue.23, pp.12911-12917, 2007. ,
DOI : 10.1128/JVI.01522-07
Antigenic Fingerprinting of H5N1 Avian Influenza Using Convalescent Sera and Monoclonal Antibodies Reveals Potential Vaccine and Diagnostic Targets, PLoS Medicine, vol.80, issue.1, 2009. ,
DOI : 10.1371/journal.pmed.1000049.s006
Cross-Reactive Neuraminidase Antibodies Afford Partial Protection against H5N1 in Mice and Are Present in Unexposed Humans, PLoS Medicine, vol.41, issue.2, 2007. ,
DOI : 10.1371/journal.pmed.0040059.g005
Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys, Vaccine, vol.22, issue.23-24, pp.2993-3003, 2004. ,
DOI : 10.1016/j.vaccine.2004.02.021
Influenza A virus infection engenders a poor antibody response against the ectodomain of matrix protein 2, Virology Journal, vol.3, issue.1, p.102, 2006. ,
DOI : 10.1186/1743-422X-3-102
Heterosubtypic Neutralizing Monoclonal Antibodies Cross-Protective against H5N1 and H1N1 Recovered from Human IgM+ Memory B Cells, PLoS ONE, vol.81, issue.12, 2008. ,
DOI : 10.1371/journal.pone.0003942.s001
Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses, Nature Structural & Molecular Biology, vol.371, issue.3, pp.265-273, 2009. ,
DOI : 10.1038/nsmb.1566
Antibody recognition of a highly conserved influenza virus epitope. Science; E-pub 26, 2009. ,